Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Dose Carbidopa in Parkinson's Disease
NCT01399905Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Mar 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carbidopa in Parkinson's disease (PD) (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Area Under the Curve (AUC) of Tapping Speed at 4 weeks. Started Mar 2009; status: completed.
02
Drugs
carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01399905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01399905.